19018-Lung Cancer-NA-1269

Lung Cancer

516-005: A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy and Checkpoint Inhibitor Therapy (SAPPHIRE)

  • Details

ClinicalTrials.gov ID: NCT03906071
Diagnosis Type: NA
USOR Number:

  • Address

11850 Blackfoot St NW, Suite 100
Coon Rapids, MN 55433
P: (763) 712-2100

Search by practice name, trial titles, indicators and specific disease types.